Zobrazeno 1 - 10
of 100
pro vyhledávání: '"Francesca, Schiavi"'
Autor:
Maria Chiara Scaini, Cristina Catoni, Cristina Poggiana, Jacopo Pigozzo, Luisa Piccin, Kevin Leone, Ilaria Scarabello, Antonella Facchinetti, Chiara Menin, Lisa Elefanti, Stefania Pellegrini, Valentina Aleotti, Riccardo Vidotto, Francesca Schiavi, Alessio Fabozzi, Vanna Chiarion-Sileni, Antonio Rosato
Publikováno v:
npj Precision Oncology, Vol 8, Iss 1, Pp 1-16 (2024)
Abstract Melanoma heterogeneity is a hurdle in metastatic disease management. Although the advent of targeted therapy has significantly improved patient outcomes, the occurrence of resistance makes monitoring of the tumor genetic landscape mandatory.
Externí odkaz:
https://doaj.org/article/168759f0adb14fe5b0f672e54dd70bb5
Autor:
Raffaele Scafa, Maurizio Merico, Alfonso Massimiliano Ferrara, Sara Watutantrige Fernando, Pava Srsen, Francesca Schiavi, Stefania Zovato, Alberto Ferlin
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
We report the case of a 38-year-old man whose diagnostic workup for primary infertility led to the discovery of obstructive azoospermia due to bilateral papillary cystadenoma of the epididymis (PCE). Given the rarity of this finding and because PCE c
Externí odkaz:
https://doaj.org/article/30faf836f61e472ba9e11622e4795cf8
Autor:
Simone De Fabritiis, Silvia Valentinuzzi, Gianluca Piras, Ilaria Cicalini, Damiana Pieragostino, Sara Pagotto, Silvia Perconti, Mirco Zucchelli, Alberto Schena, Elisa Taschin, Gloria Simona Berteşteanu, Diana Liberata Esposito, Antonio Stigliano, Vincenzo De Laurenzi, Francesca Schiavi, Mario Sanna, Piero Del Boccio, Fabio Verginelli, Renato Mariani-Costantini
Publikováno v:
Oncogenesis, Vol 12, Iss 1, Pp 1-10 (2023)
Abstract Head and neck paragangliomas (HNPGLs), rare chemoresistant tumors curable only with surgery, are strongly influenced by genetic predisposition, hence patients and relatives require lifetime follow-up with MRI and/or PET-CT because of de novo
Externí odkaz:
https://doaj.org/article/7b6e67383b2a44df9409d4bd0a478350
Autor:
Jean-Pierre Bayley, Heggert G Rebel, Kimberly Scheurwater, Dominique Duesman, Juan Zhang, Francesca Schiavi, Esther Korpershoek, Jeroen C Jansen, Abbey Schepers, Peter Devilee
Publikováno v:
PLoS ONE, Vol 17, Iss 9, p e0274478 (2022)
The neuroendocrine tumours paraganglioma and pheochromocytoma (PPGLs) are commonly associated with succinate dehydrogenase (SDH) gene variants, but no human SDH-related PPGL-derived cell line has been developed to date. The aim of this study was to s
Externí odkaz:
https://doaj.org/article/77e6473da3044bd4aad2ade1aaa4bf3c
Autor:
Francesco Sabbatino, Luigi Liguori, Umberto Malapelle, Francesca Schiavi, Vincenzo Tortora, Valeria Conti, Amelia Filippelli, Giampaolo Tortora, Cristina R. Ferrone, Stefano Pepe
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
IntroductionIntrahepatic cholangiocarcinoma (ICC) is a rare hepatobiliary cancer characterized by a poor prognosis and a limited response to conventional therapies. Currently chemotherapy is the only therapeutic option for patients with Stage IV ICC.
Externí odkaz:
https://doaj.org/article/99a02493350d41458998a976d2c3a8fd
Autor:
Carlotta Pozza, Franz Sesti, Carla Di Dato, Emilia Sbardella, Riccardo Pofi, Francesca Schiavi, Vincenzo Bonifacio, Andrea M. Isidori, Antongiulio Faggiano, Andrea Lenzi, Elisa Giannetta
Publikováno v:
Frontiers in Endocrinology, Vol 11 (2020)
Introduction: Pheochromocytomas (PCCs), paragangliomas (PGLs), ganglioneuroblastomas (GNBs), and ganglioneuromas (GNs) are neuroendocrine neoplasms (NENs) that were thought to share a common embryologic origin from neural crest cells. However, they r
Externí odkaz:
https://doaj.org/article/7ea7eaf0cf4f4da6b7a5dbbffb78acb4
Autor:
Matteo Fassan, Antonio Collesei, Valentina Angerilli, Marta Sbaraglia, Francesco Fortarezza, Federica Pezzuto, Monica De Gaspari, Gianluca Businello, Margherita Moni, Stefania Rizzo, Giulia Traverso, Veronica Colosso, Elisa Taschin, Francesca Lunardi, Aida Freire Valls, Francesca Schiavi, Cristina Basso, Fiorella Calabrese, Angelo Paolo Dei Tos
Publikováno v:
Cells, Vol 11, Iss 6, p 1011 (2022)
The transcriptomic profiling of lung damage associated with SARS-CoV-2 infection may lead to the development of effective therapies to prevent COVID-19-related deaths. We selected a series of 21 autoptic lung samples, 14 of which had positive nasopha
Externí odkaz:
https://doaj.org/article/1e50bc0cc66a4b2a89b67f72f08588d7
Autor:
Mercedes Robledo, Anne-Paule Gimenez-Roqueplo, Judith Favier, Mario F. Fraga, Cristina Rodríguez-Antona, Alberto Cascon, Ronald de Krijger, Felix Beuschlein, Henri Timmers, Guiseppe Opocher, Massimo Mannelli, Graeme Eisenhofer, Veronika Mancikova, Francesca Schiavi, Iñaki Comino-Méndez, Agustin F. Fernández, Maria Currás-Freixes, Eric Letouzé, Lucia Inglada-Pérez, Esther Korpershoek, Aguirre A. de Cubas
Supplemental Table 1. Detailed clinical data for PPGL samples.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ce4e2b1231a345c3d9ef1a1278c44c3
https://doi.org/10.1158/1078-0432.22457859.v1
https://doi.org/10.1158/1078-0432.22457859.v1
Autor:
Mercedes Robledo, Anne-Paule Gimenez-Roqueplo, Judith Favier, Mario F. Fraga, Cristina Rodríguez-Antona, Alberto Cascon, Ronald de Krijger, Felix Beuschlein, Henri Timmers, Guiseppe Opocher, Massimo Mannelli, Graeme Eisenhofer, Veronika Mancikova, Francesca Schiavi, Iñaki Comino-Méndez, Agustin F. Fernández, Maria Currás-Freixes, Eric Letouzé, Lucia Inglada-Pérez, Esther Korpershoek, Aguirre A. de Cubas
Purpose: Pheochromocytoma and paraganglioma (PPGL) are rare neuroendocrine tumors, associated with highly variable postoperative evolution. The scarcity of reliable PPGL prognostic markers continues to complicate patient management. In this study, we
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0267dbca633ac30e970a81ab53507031
https://doi.org/10.1158/1078-0432.c.6523728
https://doi.org/10.1158/1078-0432.c.6523728
Autor:
Pierfranco Conte, Antonio Rosato, Gian Luca De Salvo, Marcello Lo Mele, Giovanna Magni, Claudia Pinato, Francesca Schiavi, Loredana Urso, Tommaso Giarratano, Gaia Griguolo, Grazia Maria Vernaci, Gabriella Moretti, Simon Spazzapan, Antonino Musolino, Giancarlo Bisagni, Anna Tosi, Valentina Guarneri, Maria Vittoria Dieci
Purpose:The role of immunotherapy in hormone receptor (HR)-positive, HER2-negative breast cancer is underexplored.Patients and Methods:The neoadjuvant phase II GIADA trial (NCT04659551, EUDRACT 2016-004665-10) enrolled stage II–IIIA premenopausal p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::449a9fe461a52ff1aa0af6c33fa436d4
https://doi.org/10.1158/1078-0432.c.6531084
https://doi.org/10.1158/1078-0432.c.6531084